<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9100935</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1199</journal-id>
<journal-id journal-id-type="nlm-ta">Neuroreport</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuroreport</journal-id>
<journal-title-group>
<journal-title>Neuroreport</journal-title>
</journal-title-group>
<issn pub-type="ppub">0959-4965</issn>
<issn pub-type="epub">1473-558X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28915148</article-id>
<article-id pub-id-type="pmc">6503668</article-id>
<article-id pub-id-type="doi">10.1097/WNR.0000000000000905</article-id>
<article-id pub-id-type="manuscript">NIHMS1025536</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Adult <italic>Fmr1</italic> knockout mice present with deficiencies in hippocampal IL-6 and TNFα expression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hodges</surname>
<given-names>Samantha L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nolan</surname>
<given-names>Suzanne O.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taube</surname>
<given-names>Joseph H.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lugo</surname>
<given-names>Joaquin N.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Institute of Biomedical Sciences, Baylor University, Waco, TX 76798, USA.</aff>
<aff id="A2"><label>2</label>Department of Psychology and Neuroscience, Baylor University, Waco, TX 76798, USA.</aff>
<aff id="A3"><label>3</label>Department of Biology, Baylor University, Waco, TX 76798, USA.</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Corresponding author Joaquin N. Lugo, PhD, Baylor University, Department of Psychology and Neuroscience, One Bear Place # 97334, Waco, TX 76798, Phone: 254-710-2389; FAX: 254-710-3033, <email>joaquin_lugo@baylor.edu</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P15">Statement of Conflicts of Interest: None Declared</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>26</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>13</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>07</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>28</volume>
<issue>18</issue>
<fpage>1246</fpage>
<lpage>1249</lpage>
<!--elocation-id from pubmed: 10.1097/WNR.0000000000000905-->
<abstract id="ABS1">
<p id="P1">Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by a single genetic mutation in the <italic>Fmr1</italic> gene. Mutations in the <italic>Fmr1</italic> gene are the largest monogenic cause of Autism spectrum disorder (ASD), and thus both disorders share many of the same cognitive and behavioral impairments. There is increasing evidence suggesting dysregulated immune responses play a role in the pathophysiology of ASD, however, the association between FXS and altered immunity requires further investigation. This study examined whether <italic>Fmr1</italic> knockout (KO) and wild type (WT) mice on a FVB/NJ background strain had altered cytokine expression at baseline levels in the hippocampus. Results showed <italic>Fmr1</italic> KO mice to have decreased pro-inflammatory cytokine hippocampal mRNA expression, specifically IL-6 and TNFα, compared to WT mice. However, no differences were detected in the expression levels of IL-1β, MCP-1, IFNγ, or IL-10. Despite the high comorbidity between FXS and ASD, these results suggest that the <italic>Fmr1</italic> KO mouse does not mimic the increased pro-inflammatory cytokine expression commonly found in ASD mouse models and patients. Further investigation of the immune profile of the <italic>Fmr1</italic> KO mouse is critical to understand whether this deficiency of cytokines in the hippocampus is indicative of a broader immunologic deficit associated with FXS.</p>
</abstract>
<kwd-group>
<kwd>Fragile X syndrome</kwd>
<kwd>FXS</kwd>
<kwd>autism</kwd>
<kwd>cytokines</kwd>
<kwd>IL-6</kwd>
<kwd>TNFα</kwd>
<kwd>inflammation</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>